Not available
Quote | Aptevo Therapeutics Inc. (NASDAQ:APVO)
Last: | $4.69 |
---|---|
Change Percent: | 0.25% |
Open: | $4.05 |
Close: | $4.69 |
High: | $4.9979 |
Low: | $3.95 |
Volume: | 293,949 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Aptevo Therapeutics Inc. (NASDAQ:APVO)
2024-03-18 23:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SEATTLE, WA / ACCESSWIRE / March 18, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that the ...
Message Board Posts | Aptevo Therapeutics Inc. (NASDAQ:APVO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $APVO News Article - Aptevo Therapeutics Files Provisional Patent for Fifth Bispecific | whytestocks | investorshangout | 01/09/2023 7:35:48 PM |
It never does for those that hold.... ;-) | pinkslipjunkie | investorshub | 12/12/2022 11:32:28 PM |
znewcar1: $APVO 12% v39,4M c3.91 f5,091M H7.20 ML2.88 gapNcrap | znewcar1 | investorshangout | 12/12/2022 11:07:56 PM |
Almost a 1000 times normal volume and it's | ErnieBilco | investorshub | 12/12/2022 8:23:39 PM |
On December 12, 2022, Aptevo Therapeutics Inc. (Aptevo | ErnieBilco | investorshub | 12/12/2022 1:39:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Aptevo Therapeutics Inc. Company Name:
APVO Stock Symbol:
NASDAQ Market:
Aptevo Therapeutics Inc. Website:
2024-03-18 23:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SEATTLE, WA / ACCESSWIRE / March 18, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that the ...
Thursday, Alligator Bioscience AB and Aptevo Therapeutics Inc (NASDAQ:APVO) released interim data from the dose escalation phas...